Sign inJoin waitlistJoin the waitlist

Joanna Kolodney

Associate Professor, Department of Medical Oncology · West Virginia University School of Medicine

Credentials: · · · · · ·

History

West Virginia University School of Medicine
Present

Hematology and Medical Oncology
University of California
2004–2007
Greater Portland Health
2001–2004
NYU Hospitals Center
1999–2000
University of Arizona College of Medicine
1995–1999

Research

New mechanistic explanation for the localization of ulcers in the rat duodenum: role of iron and selective uptake of cysteamine
Archives of Biochemistry and Biophysics · 2012 · 16 citations
Hereditary Trichilemmal Cysts are Caused by Two Hits to the Same Copy of the Phospholipase C Delta 1 Gene (PLCD1)
Scientific Reports · 2020 · Last of 8 authors · 13 citations
Smoking is associated with adrenal adenomas and adrenocortical carcinomas: a nationwide multicenter analysis
Cancer Treatment and Research Communications · 2020 · Last of 9 authors · Corresponding · 11 citations

Michael Kolodney
5 papers
Ahmed Yousaf
2 papers
Erica Ghareeb
2 papers
Jessica Patterson
2 papers · 2 as a resident
Megan Willard
2 papers
SI
Sanjana Iyengar
2 papers · 2 as a resident
Thomas Hogan
2 papers
Abdullah Al-Bouri
1 paper · 1 as a resident
AH
Alex Holliday
1 paper
Amelia Adcock
1 paper
Ann Murray
1 paper
AL
Asher Louden
1 paper

Clinical trials

Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum
Principal investigator · Recruiting · Phase 1
West Virginia University
2026–2027
Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
Principal investigator · Withdrawn · Early phase 1
West Virginia University
2020–2022
Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells
Principal investigator · Terminated · Early phase 1
West Virginia University
2019–2021
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
Site PI · Recruiting · Phase 2, Phase 3
TuHURA Biosciences, Inc.
2025–2032